The WHO on Monday tweeted, "We're aware that many people are waiting for WHO's recommendation for Covaxin to be included in the COVID-19 Emergency Use Listing, but we cannot cut corners." The WHO said Bharat Biotech has been submitting data and WHO experts have reviewed it. "WHO is expecting one additional piece of information from the company today," it added.
The WHO on Monday tweeted, "We're aware that many people are waiting for WHO's recommendation for Covaxin to be included in the COVID-19 Emergency Use Listing, but we cannot cut corners." The WHO said Bharat Biotech has been submitting data and WHO experts have reviewed it. "WHO is expecting one additional piece of information from the company today," it added.
